{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:46:02Z","timestamp":1776185162873,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.leukres.2022.107002","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:33:45Z","timestamp":1671190425000},"page":"107002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7483-0478","authenticated-orcid":false,"given":"Qianghua","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5172-6539","authenticated-orcid":false,"given":"Davidson","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9857-6440","authenticated-orcid":false,"given":"Entsar","family":"Eladl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose-Mario","family":"Capo-Chichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis Dong Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2022.107002_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40880-016-0108-0","article-title":"The Philadelphia chromosome in leukemogenesis","volume":"35","author":"Kang","year":"2016","journal-title":"Chin. J. Cancer"},{"issue":"4","key":"10.1016\/j.leukres.2022.107002_bib2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1309\/B4NVER1AJJ84CTUU","article-title":"Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis","volume":"127","author":"Soupir","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.leukres.2022.107002_bib3","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2020.083","article-title":"NPM1 Mutated, BCR-ABL1 positive myeloid neoplasms: review of the literature","volume":"12","author":"Catalano","year":"2020","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.leukres.2022.107002_bib4","first-page":"423","article-title":"Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features","volume":"81","author":"Cuneo","year":"1996","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.leukres.2022.107002_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/10428194.2012.701739","article-title":"Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia","volume":"54","author":"Konoplev","year":"2013","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.leukres.2022.107002_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.leukres.2003.10.027","article-title":"Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature","volume":"28","author":"Keung","year":"2004","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2022.107002_bib7","doi-asserted-by":"crossref","unstructured":"D. Grimwade, R.K. Hills, A.V. Moorman, H. Walker, S. Chatters, A.H. Goldstone, K. Wheatley, C.J. Harrison, A.K. Burnett, G. National Cancer Research Institute Adult Leukaemia Working, Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials, BLOOD 116(3) (2010) 354\u2013365.","DOI":"10.1182\/blood-2009-11-254441"},{"issue":"20","key":"10.1016\/j.leukres.2022.107002_bib8","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2022.107002_bib9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.bbmt.2018.04.020","article-title":"Impact of an additional chromosome on the clinical outcomes of hematopoietic stem cell transplantation in philadelphia chromosome-positive acute myeloid leukemia in adults","volume":"24","author":"Min","year":"2018","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"1","key":"10.1016\/j.leukres.2022.107002_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajh.24928","article-title":"Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)","volume":"93","author":"Lazarevic","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2022.107002_bib11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2022.107002_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/bjh.12301","article-title":"Does BCR\/ABL1 positive acute myeloid leukaemia exist?","volume":"161","author":"Nacheva","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.leukres.2022.107002_bib13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00277-016-2721-z","article-title":"BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features","volume":"95","author":"Neuendorff","year":"2016","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2022.107002_bib14","unstructured":"S.L.G.M.-J.J.S.M. International Standing Committee on Human Cytogenetic Nomenclature, ISCN 2013: an international system for human cytogenetic nomenclature (2013), Karger, Basel, 2013."},{"issue":"8","key":"10.1016\/j.leukres.2022.107002_bib15","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41409-021-01255-4","article-title":"Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia","volume":"56","author":"Daher-Reyes","year":"2021","journal-title":"Bone Marrow Transpl."},{"issue":"1","key":"10.1016\/j.leukres.2022.107002_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0145-2126(03)00180-2","article-title":"Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia","volume":"28","author":"Chang","year":"2004","journal-title":"Leuk. Res"},{"issue":"10","key":"10.1016\/j.leukres.2022.107002_bib17","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.leukres.2011.04.011","article-title":"Incidence of Philadelphia-chromosome in acute myelogenous leukemia and biphenotypic acute leukemia patients: And its role in their outcome","volume":"35","author":"Atfy","year":"2011","journal-title":"Leuk. Res"},{"issue":"3","key":"10.1016\/j.leukres.2022.107002_bib18","first-page":"545","article-title":"Clinical analysis of 12 cases of acute myeloid leukemia with Ph chromosome and BCR-ABL positive","volume":"20","author":"Fei","year":"2012","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.leukres.2022.107002_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/gcc.22936","article-title":"Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study","volume":"60","author":"Orsmark-Pietras","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2022.107002_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/leu.2016.231","article-title":"Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy","volume":"31","author":"Chen","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2022.107002_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2257.2002.00413.x","article-title":"BCR\/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML)","volume":"24","author":"Arana-Trejo","year":"2002","journal-title":"Clin. Lab Haematol."},{"issue":"13","key":"10.1016\/j.leukres.2022.107002_bib22","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1182\/blood-2008-04-148791","article-title":"BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemias","volume":"112","author":"Jones","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2022.107002_bib23","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/leu.2017.86","article-title":"The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia","volume":"31","author":"Eisfeld","year":"2017","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2022.107002_bib24","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2217\/fon-2017-0523","article-title":"The role of IDH mutations in acute myeloid leukemia","volume":"14","author":"Montalban-Bravo","year":"2018","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2022.107002_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5045\/br.2021.2021152","article-title":"IDH1\/2 mutations in acute myeloid leukemia","volume":"57","author":"Byun","year":"2022","journal-title":"Blood Res."},{"issue":"21","key":"10.1016\/j.leukres.2022.107002_bib26","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1182\/blood-2010-06-292433","article-title":"CBL, CBLB, TET2, ASXL1, and IDH1\/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia","volume":"117","author":"Makishima","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2022.107002_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/leu.2010.236","article-title":"IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis","volume":"25","author":"Soverini","year":"2011","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.leukres.2022.107002_bib28","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.leukres.2022.107002_bib29","first-page":"2059","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research","year":"2013"},{"issue":"1","key":"10.1016\/j.leukres.2022.107002_bib30","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/s41467-021-23097-w","article-title":"Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia","volume":"12","author":"Ochi","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.leukres.2022.107002_bib31","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/bmt.2015.206","article-title":"S.-T. group, Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy","volume":"50","author":"Chantepie","year":"2015","journal-title":"Bone Marrow Transpl."},{"issue":"12","key":"10.1016\/j.leukres.2022.107002_bib32","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/bloodadvances.2018015594","article-title":"BCR-ABL(+) acute myeloid leukemia: are we always dealing with a high-risk disease?","volume":"2","author":"Neuendorff","year":"2018","journal-title":"Blood Adv."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622003782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622003782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:03:13Z","timestamp":1758934993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622003782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":32,"alternative-id":["S0145212622003782"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.107002","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.107002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107002"}}